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A B S T R A C T
Growth impairment is a major public health issue for children in Tanzania. The question remains as to whether
dietary mycotoxins play a role in compromising children's growth. We examined children's exposures to dietary
aﬂatoxin and fumonisin and potential impacts on growth in 114 children under 36months of age in Haydom,
Tanzania. Plasma samples collected from the children at 24months of age (N=60) were analyzed for aﬂatoxin
B1-lysine (AFB1-lys) adducts, and urine samples collected between 24 and 36months of age (N=94) were
analyzed for urinary fumonisin B1 (UFB1). Anthropometric, socioeconomic, and nutritional parameters were
measured and growth parameter z-scores were calculated for each child. Seventy-two percent of the children had
detectable levels of AFB1-lys, with a mean level of 5.1 (95% CI: 3.5, 6.6) pg/mg albumin; and 80% had de-
tectable levels of UFB1, with a mean of 1.3 (95% CI: 0.8, 1.8) ng/ml. This cohort had a 75% stunting rate [height-
for-age z-scores (HAZ) < −2] for children at 36months. No associations were found between aﬂatoxin ex-
posures and growth impairment as measured by stunting, underweight [weight-for-age z-scores (WAZ) < −2],
or wasting [weight-for-height z-scores (WHZ) < −2]. However, fumonisin exposure was negatively associated
with underweight (with non-detectable samples included, p=0.0285; non-detectable samples excluded,
p=0.005) in this cohort of children. Relatively low aﬂatoxin exposure at 24months was not linked with growth
impairment, while fumonisin exposure at 24–36months based on the UFB1 biomarkers may contribute to the
high growth impairment rate among children of Haydom, Tanzania; which may be associated with their breast
feeding and weaning practices.
1. Introduction
Growth impairment is one of the key indicators of child malnutri-
tion, and is an underlying cause in 2.9 million deaths in children under
age 5 worldwide in 2011 (Black et al., 2013). Beyond the indication of
malnutrition, childhood stunting, underweight, and wasting have been
associated with increased vulnerability to infectious diseases, cognitive
impairment lasting well beyond childhood, and potentially reduced
adulthood achievement (Blössner and Onis, 2005; Schaible and
Kaufmann, 2007; Guerrant et al., 2008; Victora et al., 2008). Most of
these cases of child growth impairment occur in resource-poor regions
of the world in Africa, South Asia, and Central America (Black et al.,
2013).
There are an estimated 130 deaths of children under age ﬁve every
day in Tanzania (URT and UNICEF, 2016). Growth impairment may
play an important role in these deaths. Tanzania has the third highest
rate of childhood stunting and underweight among African nations,
after Ethiopia and the Democratic Republic of Congo (United Republic
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of Tanzania (URT) and United Nations Children's Fund (UNICEF),
2016). In 2016, the prevalence of stunting (height-for-age z-score <
−2), underweight (weight-for-age z-score < −2) and wasting
(weight-for-height z-scores < −2) for children under ﬁve years old
was 34%, 14%, and 5%, respectively (MoHCDGEC et al., 2016). Al-
though multiple factors are involved in child growth impairment, there
has been a growing interest in understanding the role of dietary and
environmental toxins in increasing the risk.
Aﬂatoxin is a dietary mycotoxin produced by the fungi Aspergillus
ﬂavus and A. parasiticus, which commonly infect food crops in warm
climates worldwide (Kensler et al., 2011) The main sources of aﬂatoxin
exposure in humans are maize and groundnuts, which are consumed in
signiﬁcant amounts by many populations worldwide; particularly in
low- and middle-income nations in tropical/subtropical climates
(Villers, 2014; Wu and Guclu, 2012). “Naturally occurring mixes of
aﬂatoxins” are classiﬁed as a Group 1 human carcinogen by the Inter-
national Agency for Research on Cancer (IARC, 1993). Aﬂatoxin ex-
posure causes hepatocellular carcinoma (HCC), or liver cancer, which is
the third-leading cause of cancer deaths worldwide. Most of these
aﬂatoxin-related cancer cases occur in sub-Saharan Africa, China, and
Southeast Asian countries where people subsist largely on cereal and
cereal products (Liu and Wu, 2010). Moreover, extremely high doses of
aﬂatoxin may cause acute aﬂatoxicosis in animals and humans; symp-
toms include internal hemorrhaging, acute liver damage, edema, and
death (Khlangwiset et al., 2011). In the last two decades, interest has
grown in the potential role of aﬂatoxin in child growth impairment and
various epidemiological studies have shown associations between
aﬂatoxin exposure and growth impairment among children in Africa
and the Middle East, where maize and nuts are dietary staples (Gong
et al., 2002, 2004; Okoth and Ohingo, 2004; Turner et al., 2003, 2007;
Shuaib et al., 2010). However, two recent studies did not ﬁnd an as-
sociation between aﬂatoxin exposure and impaired growth of children
in Nepal and Tanzania (Mitchell et al., 2017; Shirima et al., 2015).
Fumonisin, another mycotoxin, is produced by the fungi Fusarium
verticillioides and F. proliferatum species, which also commonly infect
maize and maize-based products in warm climates worldwide.
Fumonisin B1, which is the most prevalent form of fumonisins, has been
classiﬁed by IARC as a Group 2B possible human carcinogen (IARC,
2002). The Joint FAO/WHO Expert Committee on Food Additives
(JECFA) established a provisional maximum tolerable daily intake
(PMTDI) for fumonisins of 2 μg/kg bw/day on the basis of a no observed
adverse eﬀect level (NOAEL) for nephrotoxicity in male rats and an
extrapolation factor of 100 (Bulder et al., 2012). Fumonisin has been
shown to be associated with esophageal cancer in Asian and South
African adult populations: higher fumonisin exposure from dietary
sources correlated with higher number of esophageal cancer cases
(Alizadeh et al., 2012; Shephard et al., 2002; Sun et al., 2007, 2011);
and neural tube defects (NTDs) in human babies whose mothers were
exposed to high level of fumonisins through consumption of maize-
based food during the ﬁrst trimester of pregnancy (Missmer et al.,
2006).
Although dietary fumonisin intake is high among young children in
rural areas of sub-Saharan African countries (Kimanya et al., 2010),
only two epidemiological studies on the relationship between fumo-
nisin exposure and child growth have been conducted. Kimanya et al.
(2010) found that infants in Tanzania with relatively higher fumonisin
intakes (exceeding the JECFA's PMTDI of 2 μg/kg bw/day, estimated
from caregivers' dietary recall questionnaires) were signiﬁcantly shorter
and lighter than those whose fumonisin intakes were below the JECFA's
guidance value (Kimanya et al., 2010). Shirima et al. (2015) reported
that there was a negative relationship between fumonisin exposure and
child growth among children from four villages in Tanzania, based on
validated urinary biomarker levels of fumonisin exposure. By contrast,
aﬂatoxin exposure did not have a signiﬁcant impact independently on
child growth in these cohorts; although co-exposure to these two my-
cotoxins was associated with impaired growth. It was concluded that
fumonisin exposure is a signiﬁcant risk factor in length and weight of
the young children after the covariates were adjusted. However, other
risk factors such as micronutrient status or exposure to infectious agents
were not taken into account in these studies. The Etiology, Risk Factors,
and Interactions of Enteric Infections and Malnutrition and the Con-
sequences for Child Health and Development program (MAL-ED) is a
multi-institutional project led by the Foundation of the National In-
stitutes of Health (FNIH, 2018). It is a prospective longitudinal cohort
study examining children from birth to 36months of age, to identify
risk factors compromising child health and development in eight low-
to middle-income sites worldwide (MAL-ED Network Investigators,
2014). Traditionally, vitamin deﬁciencies, poor hygiene and lack of
sanitation facilities (water scarcity and poor quality, lack of access to
proper toilets), and infectious diseases (e.g. diarrhea, malaria) and
dietary behaviors, including favoring boys over girls in food availability
have been considered major risk factors in child growth impairment in
low-income countries (Hadley et al., 2008; Katona and Katona-Apte,
2008; Levinson et al., 2004; Schmidt, 2014). However, after interven-
tions were implemented to reduce growth impairment in some West
African countries, including micronutrient supplementation and routine
vaccinations, child stunting rates remain high (Ahmed et al., 2012).
These results suggest the presence of other factors in stunting in these
high-risk populations.
A contributing factor to poor growth may be dietary toxins.
Mycotoxins are common contaminants of staple food that make up a
large proportion of weaning foods of children. This study focuses on the
potential role of dietary exposures to two of the most prevalent my-
cotoxins in maize - aﬂatoxin and fumonisin - on children's growth at the
ages of 24 to 36months of life in Haydom, Tanzania.
2. Materials and methods
2.1. Study design and description of study site
A detailed study design for the entire MAL-ED network of in-
vestigators is provided in the series of MAL-ED publications (MAL-ED
Network Investigators, 2014). The Tanzania site within the MAL-ED
network is Haydom, located in northcentral Tanzania approximately
300 km from Arusha. Haydom has a population of about 23,000 in-
habitants of various ethnicities, and is a geographically diverse set of
rural villages. This MAL-ED study area was chosen due to the com-
paratively high rates of growth impairment which is 55% among chil-
dren aged 24 to 60months according to a recent study (Psaki et al.,
2014), the presence of Haydom Lutheran Hospital, and its clinics that
support an eﬃcient reproductive health system across the area (Ahmed
et al., 2012; Mduma et al., 2014). In the present study, mother-infant
dyads were recruited from communities within the Manyara Region of
Haydom, Tanzania over a 2-year period beginning in November 2009.
Determination of included study areas within the Manyara region is
described in detail in Mduma et al. (2014). Location relative to Haydom
Lutheran Hospital and child growth parameters were determining fac-
tors for inclusion of speciﬁc villages into the cohort. The Haydom co-
hort is a socioeconomically marginalized, rural community consisting
primarily of subsistence farming households. Selection bias was mini-
mized by deﬁning a representative mother/child population and
screening every mother for eligibility. Inclusion criteria included: mo-
ther aged 16 years or older, singleton pregnancy, intention to remain in
the study area for at least 6 months following enrollment, and birth
weight or enrollment weight of> 1500 g. Exclusion criteria included
diagnosis of congenital disease or severe neonatal disease (MAL-ED
Network Investigators, 2014).
IRB approval was obtained from the National Health Research
Ethics Committee, which is part of the National Institute for Medical
Research of Tanzania, and Michigan State University. In total, plasma
samples collected at 24months of age (N=60) were utilized for
measuring aﬂatoxin B1-lysine (AFB1-lys) biomarker concentrations and
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urine samples collected between 24 and 36months of age (N=94)
were analyzed for urinary fumonisin B1 (UFB1) concentrations.
Eighteen of the participants had both a plasma and a urine sample for
the AFB1-lys and UFB1 analysis at the same timepoint of 24months.
2.2. AFB1-lys plasma biomarker analysis
AFB1-lys is a well-established biomarker of long-term dietary aﬂa-
toxin exposure during the past 2–3months. Its concentrations were
determined by liquid chromatography isotope dilution mass spectro-
metry (LC/MS) as described in Groopman et al. (2004) and McCoy et al.
(2008). Brieﬂy, plasma (200 μl) was vortexed with internal standard,
10 μl × 0.1 ng AFB1-D4-lys/ml, and pronase and incubated for 18 h at
37 °C. Samples were passed through solid-phase extraction (SPEs) col-
umns and the eluent analyzed using ultra performance liquid chroma-
tography - tandem mass spectrometer (UPLC-MS/MS). The parent ion
for AFB1-D4-lys [(M+H)+, m/z 461.3] fragmented to yield a daughter
ion at m/z 398.2. The AFB1-lys ion (m/z 457.2) fragmented to yield a
daughter ion at m/z 394.1. This methodology had a limit of detection of
0.4 pg AFB1-lys/mg albumin and was run with quality control samples
run in triplicate.
2.3. UFB1 biomarker analysis
Urinary fumonisin B1 (UFB1) has been proposed as an eﬀective
biomarker for dietary fumonisin exposure over the past 24 h, and is
currently used worldwide for biomonitoring of human fumonisin ex-
posure (van der Westhuizen et al., 2013). A signiﬁcant correlation in a
positive dose-dependent manner was observed between dietary fumo-
nisin exposure and the UFB1 levels in human populations (Riley et al.,
2015). The analytical method used for UFB1 was a minor modiﬁcation
of a method described previously (Riley et al., 2012). Brieﬂy, urine
samples (2ml) containing 10 ng of U-[13C34]-FB1 (33621 Sigma-Aldrich
Corp. St. Louis, MO, USA 33621) were extracted for FB1 with C18-SPE
cartridges. The loaded cartridges were eluted using 2ml of 70% acet-
onitrile: 30% water made to 0.1% formic acid as previously described
(Riley et al., 2012). The eluates were concentrated under N2 at room
temperature, so that the ﬁnal acetonitrile-to-water concentration
(based on speciﬁc gravity) was 30%–70%, and approximately 0.1%
formic acid. Quantitation was accomplished by LC/MS as previously
described. Normalization of UFB1 concentrations was described in the
Supplemental material. The limit of detection for UFB1 is 0.01 ng/ml.
The detection limits for FB2 and FB3 are similar (Riley et al., 2012).
2.4. Anthropometrics, socioeconomic status and dietary intake
MAL-ED trained staﬀ members measured anthropometrics of chil-
dren enrolled in the study on a monthly basis. Quality control measures
included standardized techniques and instruments across study sites,
and measurements were repeated on a subset of participants. Standard
infant scales (SECA) were used to measure weight at the nearest 0.1 kg
and length measuring board or non-stretch Teﬂon synthetic tape
(SECA) was used to measure height at the nearest 0.1 cm, respectively.
Socioeconomic status (SES) is a conceptualization of an individual's,
household's or community's access to resources and can be measured
using various methodologies. Prior to initiation of recruitment and
consent among participants, the MAL-ED network undertook pre-
liminary research to determine an appropriate methodology to measure
SES that could be applicable in a multi-country study. Determination of
the critical variables and resources allowed the MAL-ED network to
formulate an index of household SES called the Water/sanitation,
Assets, Maternal education, and Income (WAMI) to be applied and
comparable across multiple countries (Psaki et al., 2014). Components
included in the WAMI index include improved access to water and sa-
nitation, wealth measured by a set of assets, maternal education, and
monthly household income. In the present study, the methodology used
for combining these components into a WAMI score was conducted
according to Psaki et al. (2014).
Mothers or other adult household members were queried monthly
(months 9–36 of the children's lives) to collect the children's 24-hour
dietary recall data, which were used to derive food and nutrient intake
information. For our analyses, we averaged monthly data points to
produce estimated intakes for two age ranges: 16–24months and
25–36months. These data were analyzed in relation to mycotoxin
biomarker concentrations. Using Haydom's food composition tables, we
quantiﬁed energy, macronutrient and micronutrient intakes including
vitamin A, zinc, iron, folate, protein, animal protein, and protein from
milk, meat, ﬁsh, poultry, eggs, and insects (Lukmanji et al., 2008).
These variables were adjusted for average total energy intake (kcal), by
calculation of the residuals from an ordinary least squares regression
analysis (Willett and Stampfer, 1986). The residual values were used in
all statistical analyses (MAL-ED Network Investigators, 2017a).
Grain-based food items measured in the dietary recall questionnaire
included rice, maize, wheat, millet, sorghum, and common beans;
whereas chickpeas and mung beans are consumed at much lower fre-
quencies. Maize makes up the main part of the children's weaning foods
(Kimanya et al., 2010). These data were averaged over the timepoints
16–24months for aﬂatoxin and 24–36months for fumonisin. The data
were normally distributed (goodness of ﬁt test, p < 0.27) and not ad-
justed for statistical analysis.
2.5. Statistical analysis
The AFB1-lys data were not normally distributed, even following
lognormal transformation. Therefore, all statistical analyses of AFB1-lys
were conducted utilizing tests for non-parametric data. UFB1 was not
normally distributed and had a signiﬁcant portion of non-detectable
values, therefore they were log (x+ 1) transformed prior to statistical
analysis. AFB1-lys, UFB1 and growth indicators were analyzed by uni-
variate analysis with all possible confounding variables (dietary intake
variables including plasma vitamin A, iron, zinc, protein and animal
protein, folate, SES index, and gender). Anthropometric data (HAZ,
WAZ and WHZ z-scores) were normally distributed and were not al-
tered for statistical analysis. Wilcox-rank sum tests were used to analyze
statistical diﬀerences between AFB1-lys or UFB1 concentrations and
categorical data. Linear regression models were built with each growth
indicator - HAZ, WAZ, and WHZ at 36months of age - as dependent
variables, and AFB1-lys or UFB1 concentrations as independent vari-
ables. A p value≤ 0.05 (two-tailed) was considered statistically sig-
niﬁcant. All statistical analyses were conducted with JMP software
version 13.1 (SAS Institute, Cary, NC, USA). In addition, both AFB1-lys
and UFB1 concentrations were categorized by quartile, and assessed by
z-scores using ANOVA followed by Tukey HSD tests to compare be-
tween quartiles and all other variables.
3. Results
3.1. Child growth and demographic variables
A total of 114 children were enrolled in the Haydom, Tanzania
cohort: 59 boys and 55 girls, with mean birth height and weight of
48.8 ± 2.52 cm and 3.27 ± 0.49 kg, respectively. At 24months, when
blood samples were taken for the AFB1-lys analysis (n= 60; 32 boys
and 28 girls), the average height and weight of the children was
79.4 ± 3.12 cm and 10.4 ± 1.31 kg at the sampling time (24months),
and averages used in association with the UFB1 analysis (n= 94; 49
boys and 45 girls) were 83.2 ± 4.19 cm and 11.3 ± 1.43 kg
(24–36months).
The child growth trajectories for HAZ, WAZ and WHZ scores are
listed in Table 1. This cohort of children had a high incidence of
stunting rate; 61% of the children had a HAZ score below −2 at
24months when blood samples were taken for the AFB1-lys analysis. At
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24months, underweight incidence (WAZ < −2) rate was 17%, and
3% of the children were wasted (WHZ < −2). At 36months, 75% of
the children were stunted, 21% were underweight, and none were
wasted.
The average WAMI score, a proxy for household socioeconomic
status, was 0.26 [95% CI: 0.24–0.29] (Table 1). The WAMI scores were
positively associated with all three growth parameters (higher socio-
economic status was associated with improved children's growth out-
comes): HAZ, p=0.0392; WAZ, p=0.0006; WHZ, p=0.0068
(Table 3; Fig. 1a, b, c). However, the WAMI was not associated with
AFB1-lys (p=0.12) or UFB1 concentrations (p=0.28).
3.2. Dietary intakes of micronutrients, proteins and grain-based foods
Table 2 shows dietary intakes of micronutrients, proteins and the
number of grain-based foods for the children in Haydom, Tanzania. The
mean intake of iron was 9.3 (95% CI: 8.8, 9.8) and 10.8 (95% CI: 10.4,
11.2) mg/day at age of 16–24 and 25–36months, respectively. For zinc,
the mean intake was 5.9 (95% CI: 5.6, 6.2) mg/day (16–24months) and
6.2 (95% CI: 6.0, 6.5) mg/day (25–36months), respectively. Intake of
vitamin A in this cohort was 168 (95% CI: 147, 188) μg/day at age of
16–24months and 140 (95% CI: 127, 154) μg/day at 25–36months. As
a main source of dietary mycotoxin exposure, the number of grain-
based food items consumed daily by the children was estimated to be
5.4 (95% CI: 5.1, 5.8) at 16–24months and 6.1 (95% CI: 5.8, 6.3) at
25–36months. Dietary intake of folate and protein was 74.2 (95% CI:
69.4, 79.1) μg/day and 32.3 (95% CI: 30.4, 34.2) g/day at
9–24months; and 88.5 (95% CI: 83.7, 93.4) μg/day and 31.7 (95% CI:
30.5, 32.8) g/day at 25–36months (Table 2).
In the univariate analyses, no signiﬁcant associations were observed
between AFB1-lys concentrations among children and dietary intake of
average protein (p=0.35), animal protein (p=0.60), iron (p=0.60),
folate (p=0.95) and vitamin A (p=0.09), nor was zinc (Spearman's
ρ=0.64) intake or grain consumption frequency (Spearman's
ρ=0.40). Similarly, none of the dietary intakes of the number of grain-
based food (p=0.058), protein (p=0.85), animal protein (p=0.80),
vitamin A (Spearman's ρ=0.66), iron (Spearman's ρ=0.66), zinc
(Spearman's ρ=0.28), folate (Spearman's ρ=0.39) signiﬁcantly cor-
related with UFB1 concentrations in children of 24–36months in
Haydom, Tanzania.
With respect to the relationship between intakes of micronutrients
and child growth indicators, iron is signiﬁcantly associated with im-
proved HAZ (p=0.028), and folate is signiﬁcantly associated with
improved WAZ (p=0.025) and WHZ (p=0.015).
Table 1
Statistics for growth indicators and socioeconomic status characteristics of child cohort in
Haydom, Tanzania.
Mean (95% CI) Median Min Max
HAZ
24months −2.45 (−2.7, −2.2) −2.29 −4.51 −0.26
36months −2.63 (−2.8, −2.4) −2.58 −5.8 −0.5
WAZ
24months −1.13 (−1.38, −0.88) −1.12 −3.89 2.02
36months −1.39 (−1.6, −1.1) −1.39 −3.93 2.02
WHZ
24months 0.21 (−0.07, 0.49) 0.3 −2.79 2.88
36months 0.14 (−0.04, 0.3) 0.055 −1.73 3.17
WAMI score 0.26 (0.24, 0.29) 0.27 0 0.59
Fig. 1. Linear regressions of WAMI index (n= 94) with HAZ (a), WAZ (b) and WHZ (c) values.
Table 2
Statistics of the mycotoxin exposure and dietary intakes for the children cohort (MAL-ED
study) in Haydom, Tanzania.
Variable Mean (95% CI) Median Min Max
AFB1-lys (pg/mg albumin) 5.1 (3.5–6.6) 3.6 0.28 25.1
UFB1 (ng/ml urine) 1.3 (0.8–1.8) 0.4 < LODa 16.6
FB1 dose (μg/kg bw/day) 13.8 (8.4–19.2) 4.4 0 162
Average Fe intake (mg/day)
16–24months 9.3 (8.8, 9.8) 9.2 5.8 13.1
25–36months 10.8
(10.4–11.2)
11.2 5.5 14.8
Average Zn intake (mg/day)
16–24months 5.9 (5.6, 6.2) 5.8 3.7 8.8
25–36months 6.2 (6.0–6.5) 6.3 3.3 8.8
Average vitamin A intake
(μg retinol equivalent (RE)/
day)
16–24months 168 (147, 188) 170 22.4 322
25–36months 140.1
(126.5–153.6)
128 19.8 322
Average folate intake (μg/day)
16–24months 74.2 (69.4,
79.1)
69.5 47.5 129
25–36months 88.5
(83.7–93.4)
84.7 34.8 145
Average protein intake (g/day)
16–24months 32.3 (30.4,
34.2)
31.5 19.9 51.4
25–36months 31.7
(30.5–32.8)
31.4 19.8 45.1
Average grain intake (# items)
16–24months 5.4 (5.1, 5.8) 5.2 3.4 8.4
25–36months 6.1 (5.8–6.3) 6.1 3.5 8.7
The AFB1-lys analysis was from serum samples collected from children at 24months of
age, and the UFB1 analysis was from urine samples collected from children at 24 to
36months of age. The intake values are the averages from 16 to 24 (n=60) and 25 to
36months of age (n= 94), respectively.
a Limit of detection.
C. Chen et al. Environment International 115 (2018) 29–37
32
3.3. Biomarker concentrations of aﬂatoxin and fumonisin
Statistical analysis of plasma biomarker concentrations for aﬂatoxin
and urine biomarker concentrations for fumonisin are listed in Table 2.
For this population of children, 72% had detectable AFB1-lys exposure
at 24months of age, with a mean level of 5.1 (95% CI: 3.5, 6.6) pg/mg
albumin; 80% had detectable levels of UFB1 with a mean level of 1.3
(95% CI: 0.8, 1.8) ng/ml urine at 25–36months of age. In total, 60
plasma samples were analyzed for AFB1-lys, 94 urine samples for UFB1,
and 40 members of the cohort had both blood and urine samples that
were analyzed for AFB1-lys (24months of age) and UFB1 (between 24
and 36months of age, with the mean age of 31.5 months). Of these, 30
children tested above the limit of detection for both AFB1-lys and UFB1.
As seen in studies in the USA (Riley et al., 2012) and Guatemala (Torres
et al., 2014), urinary FB2 and FB3 were detected at much lower levels
than expected, based on what is known about their relative abundance
in F. verticillioides-infected maize.
The daily intake of FB1 was estimated using individual UFB1 con-
centration, daily urine output, body weight, and the assumption that
0.5% of the FB1 intake is excreted in urine (Riley et al., 2012; Sup-
plemental material). The estimated mean (13.8 μg/kg bw/day) and
median (4.4 μg/kg bw/day) levels of fumonisin intake exceeded the
JECFA PMTDI of 2 μg/kg bw/day. The range was 0 to 162 μg/kg bw/
day (Table 2). Fifty-six out of 94 children in the cohort exceeded the
PMTDI and some of the high values are close to those known to cause
adverse eﬀects in animal studies (Rotter et al., 1996).
3.4. Associations between aﬂatoxin, fumonisin, and child growth markers
Analysis of associations of log-transformed AFB1-lys concentrations
with any of the anthropometric z-scores did not show any correlations
(HAZ, p=0.51; WAZ, p=0.74; WHZ, p=0.98). By comparison, re-
gression analysis of UFB1 concentrations showed a negative association
with WAZ scores (non-detectable samples excluded, p=0.0053; non-
detectable samples included, p=0.0285) (Table 4; Fig. 2a, b), but not
HAZ scores (non-detectable samples included, p=0.072; non-detect-
able samples excluded, p=0.066) or WHZ scores (non-detectable
samples included, p=0.27; non-detectable samples excluded,
p=0.060).
When UFB1 levels were divided into quartiles (n= 23 or 24/quar-
tile), there was a change in signiﬁcance; with HAZ scores (p=0.048)
and WAZ scores (p=0.031) being associated with biomarker con-
centrations of fumonisin exposure (Fig. 3), along with a signiﬁcant
diﬀerence between the 3rd and the 4th quartile (WAZ scores,
p=0.029) (Table 5). Those children in the 4th quartile (with the
highest fumonisin exposure) had the lowest mean anthropometric
measurements, with HAZ, WAZ, and WHZ scores of −3.1, −1.9, and
−0.1, respectively (Fig. 3).
4. Discussion
In this cohort of children, fumonisin exposure was associated with
underweight (with non-detectable samples included, p=0.0285; non-
detectable samples excluded, p=0.0053). Similarly, Shirima et al.
(2015) found a negative association between growth and fumonisin
exposure in children from four other villages in Tanzania. In that study,
the geometric means for fumonisin concentrations were 0.31, 0.17, and
0.57 ng/ml urine at recruitment, 6, and 12months after recruitment,
and the incidence of stunted children was 44%, 55%, and 56%, re-
spectively; which are lower than that in the present study; where the
mean UFB1 was 1.3 ng/ml and the incidence of stunting was 75%.
Therefore, there may be a dose-dependent eﬀect: greater fumonisin
exposure resulting in greater stunting risk. In contrast to the studies in
Tanzania, fumonisin exposure was low in a cohort of children in
Bhaktapur, Nepal, with only one fumonisin positive sample detected
among 50 urine samples, along with a lower stunting rate of 19%
(Mitchell et al., 2017). Because fumonisin has been found to cause re-
duced weight gain, feed conversion eﬃciency and animal growth per-
formance in mammal species such as swine, mice and rabbits (Abdel-
Wahhab et al., 2004; Adua and Gboreb, 2015; Rotter et al., 1996), it is
likely that dietary fumonisin exposure is a contributing factor to growth
impairment, and a threshold of fumonisin intake is needed to aﬀect
growth.
In the present study, 72% of the children had detectable levels of
AFB1-lys in the plasma at 24months of age; yet no associations were
found between the low aﬂatoxin exposures and growth impairment as
measured by the children's HAZ, WAZ and WHZ values. Additionally,
dietary intakes of vitamin A, iron, zinc, protein, folate, and grain
Table 3
Signiﬁcance test for linear regression coeﬃcient between HAZ, WAZ, HAZ and the WAMI
index.
Variable Regression coeﬃcient Standard error t p
HAZ
Intercept −3.38 0.31 −11.07 <0.0001
WAMI 2.23 1.06 2.11 0.0392a
WAZ
Intercept −2.08 0.22 −9.42 <0.0001
WAMI 2.66 0.75 3.54 0.0006a
WHZ
Intercept −0.42 0.24 −1.75 0.0849
WAMI 2.34 0.84 2.80 0.0068a
a Indicates there are signiﬁcant associations between HAZ, WAZ, WHZ and the WAMI
index.
Table 4
Signiﬁcance test for linear regression coeﬃcient between UFB1 concentrations (with the
non-detects excluded and included respectively) and WAZ score.
Variable Regression coeﬃcient Standard error t p
Non-detects excluded
Intercept 0.88 0.26 3.34 0.0013
WAZ −0.44 0.15 −2.87 0.0053a
Non-detects included
Intercept −1.19 0.13 −8.94 <0.0001
WAZ −0.36 0.16 −2.23 0.0285a
a Indicates there is a negative associations between fumonisin exposure and WAZ
value.
Table 5
ANOVA analysis with a Tukey HSD test between UFB1 concentrations divided by quartiles
(with non-detects included) and anthropometric z-scores (HAZ, WAZ and WHZ).
UFB1 quartile N −x ± s F p
HAZ
1 23 −2.30 ± 1.13 2.74 0.0482⁎
2 24 −2.73 ± 1.11
3 24 −2.39 ± 0.83
4 23 −3.10 ± 1.12
WAZ
1 23 −1.28 ± 0.86 3.09 0.0310⁎
2 24 −1.27 ± 1.14
3 24 −1.11 ± 0.89
4 23 −1.91 ± 0.94#
WHZ
1 23 0.03 ± 0.73 1.30 0.2810
2 24 0.35 ± 1.05
3 24 0.27 ± 1.04
4 23 −0.10 ± 0.62
⁎ Indicates an overall signiﬁcant diﬀerence.
# Indicates a signiﬁcant diﬀerence between the 3rd and the 4th quartile, with p-value
of 0.029.
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consumption frequency were not correlated with aﬂatoxin exposure.
Similarly, a recent cohort study conducted in Nepal did not ﬁnd an
association between aﬂatoxin exposure and growth impairment or
growth trajectories in children's ﬁrst 36 months of life (Mitchell et al.,
2017). The aﬂatoxin concentrations are comparable, with mean AFB1-
lys levels of 5.1 (range 0.28–25.1) and 3.62 (range 0.58–22.7) pg/mg
albumin, respectively, for children in Haydom, Tanzania and Bhak-
tapur, Nepal.
In another longitudinal study of 166 children in Tanzania, the
geometric mean for AFB1-alb concentrations based on enzyme-linked
immunosorbent assay (ELISA) method ranged from 4.7 to 23.5 pg/mg
albumin, and aﬂatoxin exposure was not associated with LAZ (length
for height z-score) (Shirima et al., 2015). Children in that cohort
(Shirima et al., 2015) had similar aﬂatoxin concentrations to those of
the children in the present study, if we incorporate a scale factor of 2.6
to account for the diﬀerent methods for aﬂatoxin analysis as was done
in other reports (Mitchell et al., 2017). However, the scaling factor is
controversial and should be used with caution. Assuming that the scale
factor of 2.6 is a reasonable way to compare results using diﬀerent
analytical methods, then higher AFB1-alb concentrations were found in
children of Benin and Togo, with a geometric mean concentration of
32.8 pg/mg albumin (Gong et al., 2004).
It is possible that relatively lower aﬂatoxin exposure levels may not
aﬀect child growth, but higher levels do. There is likely a threshold of
aﬂatoxin intake, below which child growth would not be aﬀected; and
the child cohorts that showed no association between aﬂatoxin ex-
posure and growth impairment may have been exposed to low aﬂatoxin
levels overall. However, the sample size of 60 for the analysis of aﬂa-
toxin exposure in the present Haydom cohort limits the statistical
power of association between AFB1 and child growth impairment ob-
served. Another limitation of our study is the cross-sectional nature of
the aﬂatoxin and fumonisin analyses, based on biospecimens at speciﬁc
timepoints in the children's development.
This is partially accounted for in that the biomarker used to measure
aﬂatoxin exposure is for long-term (past 2–3months). Optimally,
biospecimens for the mycotoxin analyses would have been available at
multiple timepoints to track with growth markers; however, absent the
availability, we present the exposure data that were available at speciﬁc
timepoints, and observe how they correlate with child growth at those
same points. In addition, it has been shown that aﬂatoxin biomarker
levels in African children increase over the ﬁrst 36months of life, which
is aﬀected by the weaning practices (Gong et al., 2003, 2004). The
median duration of some breastfeeding is 20months for Tanzanian
children (median duration of exclusive breastfeeding is 3months in this
population; MoHCDGEC et al., 2016). When aﬂatoxin exposure was
analyzed at 24months, this cohort of children likely had mixed breast
feeding and weaning practices. Although their aﬂatoxin exposure is
relatively low at the timepoint of 24months, it could increase when
they consume more maize-based foods later in their lifetime. When the
Fig. 2. Linear regressions of WAZ and UFB1 concentrations, with non-detects included (a; p-value= 0.0285, n= 94) and non-detects excluded (b; p-value= 0.0053, n= 75), respec-
tively.
Fig. 3. Associations of UFB1 concentrations (divided by quartiles, n= 23 or 24) with
anthropometric z-scores (HAZ, WAZ and WHZ values). The box plots show median (solid
line), the 25th and 75th percentile (upper and lower limits of the box) and 10th and the
90th percentile (error bars) for HAZ, WAZ and WHZ values. An asterisk indicates sig-
niﬁcant diﬀerence between the 3rd and the 4th quartile (p < 0.05).
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fumonisin biomarker was analyzed between 24 and 36months (mean
age was 31.5 months), most children had been weaned fully for months.
The mechanisms by which mycotoxins cause growth impairment in
children are still unclear. Fumonisin exerts toxic eﬀects through its
inhibition of ceramide synthase, which is a key enzyme in the bio-
synthesis and turnover of sphingolipids (Wang et al., 1991). Fumonisin
can also aﬀect intestinal barrier function, possibly via altered levels of
complex sphingolipids in cell membranes and alterations in sphingoid
base-1 phosphate signaling pathways (Bulder et al., 2012); and can
mediate inﬂammatory responses within the gut, which may ad-
ditionally potentiate or prolong infection within a damaged epithelium
(Masching et al., 2016). Stunted children were found to have sig-
niﬁcantly lower serum concentrations of sphingomyelins compared
with non-stunted children in rural areas of Malawi (Semba et al., 2016).
Moreover, UFB1 levels in urine have recently been shown to positively
correlate with elevated levels of sphinganine 1-phosphate and the
sphinganine 1-phosphate to sphingosine 1-phosphate ratio in blood in a
dose dependent manner in women in Guatemala; a result consistent
with fumonisin inhibition of ceramide synthase in humans (Riley et al.,
2015).
In addition to the biochemical mechanisms described above, enteric
diseases have been associated with malnutrition, and malnourished
children have a greater risk and increased severity of enteric illnesses
(Mondal et al., 2012; Petri et al., 2008). In a vicious cycle, malnutrition
contributes to the severity of the disease caused by intestinal infections,
while infection in turn causes malabsorption, which predisposes in-
dividuals to further infection and malnutrition. Studies have also
documented diarrheal illnesses in early childhood may account for a
shortfall of growth and development of children (Guerrant et al., 2008).
It is likely that the combination of both microbial and mycotoxin
toxicities and their interactions within the gut and liver play a critical
role in child growth impairment.
Child growth impairment rates increase with age in some countries
in sub-Saharan Africa. Cessation of exclusive breastfeeding and in-
troduction of complementary foods has been associated with an in-
crease in aﬂatoxin exposure because of increased consumption of
maize- and peanut-based weaning foods (Gong et al., 2003; Egal et al.,
2005). In this region of Tanzania, the median duration of exclusive
breastfeeding is just 38 days, and none of the infants in this study were
exclusively breastfed for the recommended 6months (Patil et al.,
2015). For both adults and children, maize is the primary dietary staple.
Solid or semi-solid foods including animal milk and maize porridge
(mixed with milk or water) are typically the ﬁrst weaning foods in-
troduced to infants. In general, grains are the most commonly con-
sumed food group (MoHCDGEC et al., 2016).
In the present study, the mean intake values of iron and zinc (9.3
and 5.9 mg/day, respectively at 16–24months) are higher than re-
commended nutrient intakes (RNIs) which is 5.8 and 4.1mg/day, re-
spectively, based on the moderate bioavailability (WHO, 2004). How-
ever, accounting for lower iron and zinc bioavailability in the children's
diet (comprising grains, vegetables, and animal meat at lower propor-
tions), intake values for this children cohort are still inadequate. The
recommended safe intake for vitamin A is 400 μg re-
tinol equivalent (RE)/day, and none of the children (with the range of
22.4–322 μg RE/day) in this cohort met this requirement. In Haydom,
Tanzania, about one third of children are anemic and 68% of them are
vitamin A deﬁcient at 24 months of age (MAL-ED Network
Investigators, 2017b). Although the protein intake of the children met
the adequacy recommended by WHO, the quality of protein may be
deﬁcient considering that relatively low proportion of the protein in
their diet was from animal origin products, which can aﬀect the nu-
tritional status of children in this region (Ghosh, 2016). In the present
study, a high prevalence of stunting was observed among children de-
spite their high levels of protein intakes.
In a recent nutritional analysis for children aged 6–23months in
rural central Tanzania, deﬁciency of iron, zinc and calcium in the diets
was considered as a main factor for the high prevalence of child
stunting in this area, although their diets met requirements for vitamin
A, protein and energy (Raymond et al., 2017). In addition, feeding
practices with low nutritional quality were associated with stunting
(Kulwa et al., 2015). Therefore, intervention strategies are needed to
address the nutritional inadequacies and growth impairment among
young children in Tanzania.
Poverty, education, socioeconomic and nutritional status, vaccina-
tions against diseases, and dietary behaviors are traditionally con-
sidered the most important inﬂuences on childhood development.
Among this cohort of children in Haydom, Tanzania, socioeconomic
parameters and dietary fumonisin exposure from contaminated maize
were associated with child growth outcomes.
5. Conclusions
The relatively low biomarker concentrations of aﬂatoxin at
24months of age in this cohort of children were not linked with growth
impairment, while fumonisin exposure (UFB1 concentrations) during
24–36months through contaminated maize may increase the risk of
underweight among children in Haydom, Tanzania; which may be as-
sociated with their breast feeding and weaning practices. Investigation
of the mechanism by which fumonisin may cause growth impairment in
children is recommended. Furthermore, practical interventions of fu-
monisin-reduction strategies are needed for sub-Saharan African po-
pulations with high fumonisin exposure through maize-based foods.
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